{"transactions":[{"id":4635102,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-10-03T01:02:00.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":77390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a grant of Restricted Stock. The Restricted Stock was granted to the Reporting Person pursuant to the Compensation Agreement. The Restricted Stock vested pursuant to the terms of the Compensation Agreement."}],"balance_after":210845,"source":{"system":"sec-edgar","filing":"0001493152-26-045586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226045586/ownership.xml","form_type":"4"}},{"id":4635101,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-10-03T01:02:00.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":16620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock. The Restricted Stock was granted to the Reporting Person pursuant to an executive compensation agreement, dated April 13, 2026, by and between the Issuer and the Reporting Person (the \"Compensation Agreement\") providing for quarterly grants equal to $60,000. The Restricted Stock vested pursuant to the terms of the Compensation Agreement."}],"balance_after":133455,"source":{"system":"sec-edgar","filing":"0001493152-26-045586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226045586/ownership.xml","form_type":"4"}},{"id":4635118,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-10-03T01:00:28.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer."}],"balance_after":100000,"derivative":{"exercise_price":5,"exercise_date":"2026-04-13","expiration_date":"2036-04-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-26-045576","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226045576/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-15"}},{"id":4635117,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-10-03T01:00:28.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":16806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents a grant of RSUs issued pursuant to an executive compensation agreement, dated April 13, 2026, by and between the Issuer and the Reporting Person. The RSUs vested immediately upon grant on April 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of RSUs issued pursuant to an executive compensation agreement, dated April 13, 2026, by and between the Issuer and the Reporting Person. The RSUs vested immediately upon grant on April 13, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount Beneficially Owned Following Transaction has been corrected from 262,191 to 116,835."}],"balance_after":116835,"source":{"system":"sec-edgar","filing":"0001493152-26-045576","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226045576/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-15"}},{"id":687273,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:35:11.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":44820,"price":3.69,"value":165385.8,"ownership":{"direct":true},"balance_after":280757,"source":{"system":"sec-edgar","filing":"0001493152-26-038455","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315226038455/ownership.xml","form_type":"4"}},{"id":687272,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:35:11.000Z","date":"2026-06-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":44820,"price":3.7,"value":165834.0,"ownership":{"direct":true},"balance_after":325577,"source":{"system":"sec-edgar","filing":"0001493152-26-038455","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315226038455/ownership.xml","form_type":"4"}},{"id":687271,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:35:11.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":358565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted shares (the \"Stock Award\") of common stock, par value $0.0001 per share (\"Common Stock\"), of the Issuer granted to the Reporting Person under the Fabric.AI, Inc. Long-Term Incentive Plan (as amended, the \"Plan\"). The Stock Award vests as follows: (i) 25% vested on June 18, 2026, (ii) 25% vested on June 30, 2026, (iii) 25% will vest on September 30, 2026, and (iv) 25% will vest on December 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted shares (the \"Stock Award\") of common stock, par value $0.0001 per share (\"Common Stock\"), of the Issuer granted to the Reporting Person under the Fabric.AI, Inc. Long-Term Incentive Plan (as amended, the \"Plan\"). The Stock Award vests as follows: (i) 25% vested on June 18, 2026, (ii) 25% vested on June 30, 2026, (iii) 25% will vest on September 30, 2026, and (iv) 25% will vest on December 31, 2026."}],"balance_after":370397,"source":{"system":"sec-edgar","filing":"0001493152-26-038455","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315226038455/ownership.xml","form_type":"4"}},{"id":748137,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:12:14.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":4375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."}],"balance_after":8790450,"source":{"system":"sec-edgar","filing":"0001104659-26-071038","document":"tm2617013-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926071038/tm2617013-4_4seq1.xml","form_type":"4"}},{"id":771371,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-19T22:45:59.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following May 18, 2026."}],"balance_after":200000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-05-18","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-26-063996","document":"tm2615135-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465926063996/tm2615135-5_4seq1.xml","form_type":"4"}},{"id":808085,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-15T22:29:09.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":5,"exercise_date":"2026-04-13","expiration_date":"2036-04-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-26-016912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226016912/ownership.xml","form_type":"4"}},{"id":808084,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2026-04-15T22:29:09.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":162162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\") issued pursuant to an executive compensation agreement, dated April 13, 2026, by and between the Issuer and the Reporting Person. The RSUs vested immediately upon grant on April 13, 2026."}],"balance_after":262191,"source":{"system":"sec-edgar","filing":"0001493152-26-016912","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226016912/ownership.xml","form_type":"4"}},{"id":944965,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-07T22:43:33.000Z","date":"2026-01-07","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":0.8329,"value":33316.0,"ownership":{"direct":true},"balance_after":416250,"source":{"system":"sec-edgar","filing":"0001683168-26-000148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000148/ownership.xml","form_type":"4"}},{"id":944964,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-07T22:43:33.000Z","date":"2026-01-06","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.7889,"value":23667.0,"ownership":{"direct":true},"balance_after":376250,"source":{"system":"sec-edgar","filing":"0001683168-26-000148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000148/ownership.xml","form_type":"4"}},{"id":944963,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-07T22:43:33.000Z","date":"2026-01-05","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.7831,"value":23493.0,"ownership":{"direct":true},"balance_after":346250,"source":{"system":"sec-edgar","filing":"0001683168-26-000148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000148/ownership.xml","form_type":"4"}},{"id":955275,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T22:00:51.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":4375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts adjusted for the Issuer's 1-for-25 reverse stock split of the Issuer's Common Stock, effective as of 4:05 p.m. (New York time) on April 30, 2025."}],"balance_after":4415450,"source":{"system":"sec-edgar","filing":"0001104659-26-000238","document":"tm261718-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926000238/tm261718-4_4seq1.xml","form_type":"4"}},{"id":971644,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-12-12T22:07:33.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":258750,"price":1.02,"value":263925.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":316250,"source":{"system":"sec-edgar","filing":"0001683168-25-009114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009114/ownership.xml","form_type":"4"}},{"id":971643,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-12-12T22:07:33.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":575000,"source":{"system":"sec-edgar","filing":"0001683168-25-009114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009114/ownership.xml","form_type":"4"}},{"id":998738,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2025-11-15T01:16:44.000Z","date":"2025-11-14","kind":"grant","planned":false,"acquired":true,"shares":91356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the \"Plan Amendment\"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance."}],"balance_after":100029,"source":{"system":"sec-edgar","filing":"0001493152-25-023701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315225023701/ownership.xml","form_type":"4"}},{"id":1010887,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy","published_at":"2025-10-31T21:00:16.000Z","date":"2025-10-31","kind":"grant","planned":false,"acquired":true,"shares":220513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) 75% vested upon the date of grant; and (ii) 25% will vest on December 31, 2025, provided that the Reporting Person remains employed by or providing services to the Issuer on the applicable vesting date."}],"balance_after":220513,"derivative":{"exercise_price":6.25,"expiration_date":"2035-10-31","underlying":"Common Stock","underlying_shares":220513},"source":{"system":"sec-edgar","filing":"0001493152-25-020432","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315225020432/ownership.xml","form_type":"4"}},{"id":1016371,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-17T21:12:16.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The option grant was approved by a committee of the Issuer's board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the \"Plan\") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025."}],"balance_after":36000,"derivative":{"exercise_price":10.38,"exercise_date":"2026-07-14","expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-25-100461","document":"tm2529010-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465925100461/tm2529010-4_4seq1.xml","form_type":"4"}},{"id":1016370,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-17T21:12:16.000Z","date":"2025-10-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":40000,"price":7.23,"value":289200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":86681,"source":{"system":"sec-edgar","filing":"0001104659-25-100461","document":"tm2529010-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465925100461/tm2529010-4_4seq1.xml","form_type":"4"}},{"id":1016369,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-17T21:12:16.000Z","date":"2025-10-17","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 100,000 restricted stock units granted on October 17, 2025, under TAO Synergies Inc.'s (the \"Issuer\") 2020 Equity Incentive Plan which vested immediately and (ii) 26,681 shares of common stock."}],"balance_after":126681,"source":{"system":"sec-edgar","filing":"0001104659-25-100461","document":"tm2529010-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465925100461/tm2529010-4_4seq1.xml","form_type":"4"}},{"id":1022881,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2025-10-06T21:30:05.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":8644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs vested immediately upon grant on October 3, 2025."}],"balance_after":8673,"source":{"system":"sec-edgar","filing":"0001493152-25-017132","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315225017132/ownership.xml","form_type":"4"}},{"id":1094405,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-07-02T20:06:21.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":16768,"price":7.85,"value":131628.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":26681,"source":{"system":"sec-edgar","filing":"0001104659-25-065281","document":"tm2519649-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465925065281/tm2519649-4_4seq1.xml","form_type":"4"}},{"id":1094404,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-07-02T20:06:21.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":41919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 41,919 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,530 shares of common stock."}],"balance_after":43449,"source":{"system":"sec-edgar","filing":"0001104659-25-065281","document":"tm2519649-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465925065281/tm2519649-4_4seq1.xml","form_type":"4"}},{"id":1100011,"issuer":{"id":7510,"kind":"organization","name":"FEMASYS INC"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T21:25:24.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest one year from the date of grant, assuming continued service."}],"balance_after":17600,"derivative":{"exercise_price":0.98,"expiration_date":"2035-06-25","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001140361-25-024006","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036125024006/form4.xml","form_type":"4"}},{"id":1253121,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-21T22:33:12.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date."}],"balance_after":1011237,"source":{"system":"sec-edgar","filing":"0001104659-25-016201","document":"tm257316-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465925016201/tm257316-3_4seq1.xml","form_type":"4"}},{"id":1347656,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Cash-Settled Restricted Stock Units","published_at":"2024-12-03T02:42:31.000Z","date":"2024-12-02","kind":"exercise","planned":false,"acquired":true,"shares":97368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents a grant of cash-settled restricted stock units (\"RSUs\" and, together with the Stock Award, the \"Director Equity Awards\") granted by the Issuer to the Reporting Person. On the date of grant, the RSUs immediately converted into a cash payment equal to the fair market value of the number of shares of Common Stock equal to the same number of RSUs that were granted to the Reporting Person for the purpose of satisfying the Reporting Person's tax obligation with respect to the Director Equity Awards. No securities of the Issuer were issued, acquired or disposed of in connection with the grant of the RSUs."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a grant of cash-settled restricted stock units (\"RSUs\" and, together with the Stock Award, the \"Director Equity Awards\") granted by the Issuer to the Reporting Person. On the date of grant, the RSUs immediately converted into a cash payment equal to the fair market value of the number of shares of Common Stock equal to the same number of RSUs that were granted to the Reporting Person for the purpose of satisfying the Reporting Person's tax obligation with respect to the Director Equity Awards. No securities of the Issuer were issued, acquired or disposed of in connection with the grant of the RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents a grant of cash-settled restricted stock units (\"RSUs\" and, together with the Stock Award, the \"Director Equity Awards\") granted by the Issuer to the Reporting Person. On the date of grant, the RSUs immediately converted into a cash payment equal to the fair market value of the number of shares of Common Stock equal to the same number of RSUs that were granted to the Reporting Person for the purpose of satisfying the Reporting Person's tax obligation with respect to the Director Equity Awards. No securities of the Issuer were issued, acquired or disposed of in connection with the grant of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents a grant of cash-settled restricted stock units (\"RSUs\" and, together with the Stock Award, the \"Director Equity Awards\") granted by the Issuer to the Reporting Person. On the date of grant, the RSUs immediately converted into a cash payment equal to the fair market value of the number of shares of Common Stock equal to the same number of RSUs that were granted to the Reporting Person for the purpose of satisfying the Reporting Person's tax obligation with respect to the Director Equity Awards. No securities of the Issuer were issued, acquired or disposed of in connection with the grant of the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents a grant of cash-settled restricted stock units (\"RSUs\" and, together with the Stock Award, the \"Director Equity Awards\") granted by the Issuer to the Reporting Person. On the date of grant, the RSUs immediately converted into a cash payment equal to the fair market value of the number of shares of Common Stock equal to the same number of RSUs that were granted to the Reporting Person for the purpose of satisfying the Reporting Person's tax obligation with respect to the Director Equity Awards. No securities of the Issuer were issued, acquired or disposed of in connection with the grant of the RSUs."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Represents a grant of cash-settled restricted stock units (\"RSUs\" and, together with the Stock Award, the \"Director Equity Awards\") granted by the Issuer to the Reporting Person. On the date of grant, the RSUs immediately converted into a cash payment equal to the fair market value of the number of shares of Common Stock equal to the same number of RSUs that were granted to the Reporting Person for the purpose of satisfying the Reporting Person's tax obligation with respect to the Director Equity Awards. No securities of the Issuer were issued, acquired or disposed of in connection with the grant of the RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The securities reported as acquired herein were granted to the Reporting Person by the Issuer in lieu of any other awards previously approved by the Issuer since the beginning of the fourth quarter of the Company's 2023 fiscal year, but were never issued by the Issuer, as an annual award grant to the Reporting Person in connection with the Reporting Person's service on the Issuer's Board of Directors for 2024 and a partial annual award grant for the Reporting Person's service on the Issuer's Board of Directors for the last quarter of 2023."}],"balance_after":97368,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001493152-24-048362","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315224048362/ownership.xml","form_type":"4"}},{"id":1347655,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-12-03T02:42:31.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":146052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a grant of restricted shares of Common Stock issued under the Plan which fully vested on the date of grant (the \"Stock Award\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a grant of restricted shares of Common Stock issued under the Plan which fully vested on the date of grant (the \"Stock Award\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The securities reported herein have been adjusted for the Company's one-for-eight reverse stock split effected on September 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The securities reported as acquired herein were granted to the Reporting Person by the Issuer in lieu of any other awards previously approved by the Issuer since the beginning of the fourth quarter of the Company's 2023 fiscal year, but were never issued by the Issuer, as an annual award grant to the Reporting Person in connection with the Reporting Person's service on the Issuer's Board of Directors for 2024 and a partial annual award grant for the Reporting Person's service on the Issuer's Board of Directors for the last quarter of 2023."}],"balance_after":189323,"source":{"system":"sec-edgar","filing":"0001493152-24-048362","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315224048362/ownership.xml","form_type":"4"}},{"id":1347654,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-12-03T02:42:31.000Z","date":"2024-12-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a forfeiture of restricted shares of common stock (the \"Forfeited Shares\"), par value $0.0001 per share (\"Common Stock\"), of the Issuer granted to the Reporting Person under the AYRO, Inc. Long-Term Incentive Plan (as amended, the \"Plan\") in connection with the Reporting Person's service on the Issuer's Board of Directors that vested, but were not issued to the Reporting Person, on November 1, 2023. The Reporting Person received the Director Equity Awards (as defined herein), among other reasons as described herein, in lieu of such Forfeited Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a forfeiture of restricted shares of common stock (the \"Forfeited Shares\"), par value $0.0001 per share (\"Common Stock\"), of the Issuer granted to the Reporting Person under the AYRO, Inc. Long-Term Incentive Plan (as amended, the \"Plan\") in connection with the Reporting Person's service on the Issuer's Board of Directors that vested, but were not issued to the Reporting Person, on November 1, 2023. The Reporting Person received the Director Equity Awards (as defined herein), among other reasons as described herein, in lieu of such Forfeited Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The securities reported herein have been adjusted for the Company's one-for-eight reverse stock split effected on September 15, 2023."}],"balance_after":43271,"source":{"system":"sec-edgar","filing":"0001493152-24-048362","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315224048362/ownership.xml","form_type":"4"}},{"id":1454461,"issuer":{"id":7510,"kind":"organization","name":"FEMASYS INC"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:39:58.000Z","date":"2024-07-12","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest one year from the date of grant, assuming continued service."}],"balance_after":17600,"derivative":{"exercise_price":1.14,"expiration_date":"2034-07-12","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001140361-24-033183","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036124033183/form4.xml","form_type":"4"}},{"id":1543608,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-10T20:07:43.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 8, 2024."}],"balance_after":800,"derivative":{"exercise_price":5.39,"expiration_date":"2034-04-08","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001104659-24-045802","document":"tm2411531-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465924045802/tm2411531-3_4seq1.xml","form_type":"4"}},{"id":1700177,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-26T22:06:09.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on April 10, 2024, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-23-129250","document":"tm2333705-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129250/tm2333705-1_4seq1.xml","form_type":"4"}},{"id":1731599,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO, Interim President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:01:23.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 50% on November 20, 2023 and 50% on November 20, 2024."}],"balance_after":170000,"derivative":{"exercise_price":2.18,"expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001683168-23-008431","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008431/ownership.xml","form_type":"4"}},{"id":1730928,"issuer":{"id":7510,"kind":"organization","name":"FEMASYS INC"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T21:39:26.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in annual one-third (1/3) increments over a three (3) year period beginning on November 21, 2024, assuming continued service."}],"balance_after":17000,"derivative":{"exercise_price":0.9,"expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001140361-23-054461","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123054461/form4.xml","form_type":"4"}},{"id":1816885,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-04T00:02:16.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":12740,"price":0.8152,"value":10385.648,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8002 to $0.8450, inclusive. The reporting person undertakes to provide to AYRO, Inc., any security holder of AYRO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Represents a broker-assisted sale of shares subject to a 10b5(1) trading plan adopted by the reporting person on February 16, 2023 to pay taxes upon the vesting of an award."}],"balance_after":395493,"source":{"system":"sec-edgar","filing":"0001493152-23-026686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315223026686/ownership.xml","form_type":"4"}},{"id":1860235,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:21.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-23-020798","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020798/ownership.xml","form_type":"4"}},{"id":1903289,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T23:51:21.000Z","date":"2023-05-03","kind":"sale","planned":true,"acquired":false,"shares":11927,"price":0.4874,"value":5813.2198,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a broker-assisted sale of shares subject to a 10b5(1) trading plan adopted by the reporting person on February 16, 2023 to pay taxes upon the vesting of an award. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4700 to $0.5001, inclusive. The reporting person undertakes to provide to AYRO, Inc., any security holder of AYRO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":408233,"source":{"system":"sec-edgar","filing":"0001493152-23-015692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315223015692/ownership.xml","form_type":"4"}},{"id":1911392,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-04-28T22:00:34.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":6722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,722 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,722 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6722},"source":{"system":"sec-edgar","filing":"0001104659-23-053224","document":"tm2313909-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053224/tm2313909-1_4seq1.xml","form_type":"4"}},{"id":1911391,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-28T22:00:34.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":6722,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,722 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":11237,"source":{"system":"sec-edgar","filing":"0001104659-23-053224","document":"tm2313909-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053224/tm2313909-1_4seq1.xml","form_type":"4"}},{"id":1921050,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-12T22:01:15.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the one-year anniversary of the date of grant, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. (the \"Company\") through the vesting date."}],"balance_after":39000,"derivative":{"exercise_price":0.99,"expiration_date":"2033-04-10","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001104659-23-044712","document":"tm2312600-3_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923044712/tm2312600-3_4seq.xml","form_type":"4"}},{"id":1933775,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T20:15:42.000Z","date":"2023-03-29","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following March 29, 2023."}],"balance_after":20000,"derivative":{"exercise_price":0.87,"expiration_date":"2033-03-29","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-23-040186","document":"tm2311075-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465923040186/tm2311075-1_4seq1.xml","form_type":"4"}},{"id":2033882,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T23:29:02.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":197333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares will vest in four equal installments on each quarterly anniversary of the Grant Date, provided that Mr. Silverman is employed by or providing services to the Company through the applicable vesting date and subject to the terms and conditions of the AYRO, Inc. Long-Term Incentive Plan."}],"balance_after":420160,"source":{"system":"sec-edgar","filing":"0001493152-23-003577","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315223003577/ownership.xml","form_type":"4"}},{"id":2033881,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T23:29:02.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":7171,"price":0.7123,"value":5107.9033,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7000 to $0.7375, inclusive. The reporting person undertakes to provide to AYRO, Inc., any security holder of AYRO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Represents a broker-assisted sale of shares subject to a 10b5(1) trading plan adopted by the reporting person on August 22, 2022 to pay taxes upon the vesting of an award."}],"balance_after":222827,"source":{"system":"sec-edgar","filing":"0001493152-23-003577","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315223003577/ownership.xml","form_type":"4"}},{"id":2046522,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-25T21:17:04.000Z","date":"2023-01-20","kind":"exercise","acquired":false,"shares":2515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,515 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,515 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2515},"source":{"system":"sec-edgar","filing":"0001104659-23-006546","document":"tm234334-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006546/tm234334-3_4seq1.xml","form_type":"4"}},{"id":2046521,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:17:04.000Z","date":"2023-01-20","kind":"exercise","acquired":true,"shares":2515,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,515 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":4515,"source":{"system":"sec-edgar","filing":"0001104659-23-006546","document":"tm234334-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006546/tm234334-3_4seq1.xml","form_type":"4"}},{"id":2079491,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-12-21T01:01:55.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":19012,"price":1.1719,"value":22280.1628,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":38238,"source":{"system":"sec-edgar","filing":"0001104659-22-128770","document":"tm2233089-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465922128770/tm2233089-5_4seq1.xml","form_type":"4"}},{"id":2099780,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-12-02T00:52:23.000Z","date":"2021-07-13","kind":"grant","acquired":true,"shares":42250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This filing amends the Form 4, filed on July 15, 2021 by Mr. Silverman to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended."}],"balance_after":57250,"source":{"system":"sec-edgar","filing":"0001104659-22-123805","document":"tm2231816-6_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465922123805/tm2231816-6_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-07-15"}},{"id":2099779,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-02T00:50:16.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This filing amends the Form 4, filed on November 17, 2022 by Mr. Silverman to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vested 50% on November 15, 2022 (the \"Issuance Date\") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer."}],"balance_after":75000,"derivative":{"exercise_price":6.07,"expiration_date":"2032-11-15","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-22-123802","document":"tm2231816-4_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465922123802/tm2231816-4_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-11-17"}},{"id":2111666,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-17T21:03:13.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vested 50% on November 15, 2022 (the \"Issuance Date\") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer."}],"balance_after":144000,"derivative":{"exercise_price":6.07,"expiration_date":"2032-11-15","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001104659-22-119881","document":"tm2230820-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465922119881/tm2230820-6_4seq1.xml","form_type":"4"}},{"id":2126219,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-04T01:04:33.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":7171,"price":0.5919,"value":4244.5149,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a broker-assisted sale of shares to pay taxes upon the vesting of an award."}],"balance_after":229998,"source":{"system":"sec-edgar","filing":"0001493152-22-030401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315222030401/ownership.xml","form_type":"4"}},{"id":2126218,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-04T01:04:33.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":12855,"price":0.82,"value":10541.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale of shares to pay taxes upon the vesting of an award."}],"balance_after":237169,"source":{"system":"sec-edgar","filing":"0001493152-22-030401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315222030401/ownership.xml","form_type":"4"}},{"id":2222745,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T22:01:00.000Z","date":"2022-04-05","kind":"other","acquired":true,"shares":0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"date","element":"transactionDate","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"shares","element":"transactionShares","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Silverman, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.0001 per share"},"source":{"system":"sec-edgar","filing":"0001104659-22-073972","document":"tm2219110-3_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465922073972/tm2219110-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-04-06"}},{"id":2299485,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-11T21:01:19.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":67227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."}],"balance_after":67227,"derivative":{"underlying":"Common Stock","underlying_shares":67227},"source":{"system":"sec-edgar","filing":"0001104659-22-044715","document":"tm2212468d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922044715/tm2212468d3_4.xml","form_type":"4"}},{"id":2302281,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-06T21:01:32.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 5, 2022."}],"balance_after":1500,"derivative":{"exercise_price":7.41,"expiration_date":"2032-04-05","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-22-043275","document":"tm2212026-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465922043275/tm2212026-3_4seq1.xml","form_type":"4"}},{"id":2414854,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-03T22:08:56.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":114729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares will vest in four equal installments on each quarterly anniversary of the Grant Date, provided that Mr. Silverman is employed by or providing services to the Company through the applicable vesting date and subject to the terms and conditions of the AYRO, Inc. Long-Term Incentive Plan."}],"balance_after":250024,"source":{"system":"sec-edgar","filing":"0001493152-22-003115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315222003115/ownership.xml","form_type":"4"}},{"id":2440238,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-07T21:45:04.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":25156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"}],"balance_after":25156,"derivative":{"underlying":"Common Stock","underlying_shares":25156},"source":{"system":"sec-edgar","filing":"0001104659-22-002306","document":"tm222320d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922002306/tm222320d3_4.xml","form_type":"4"}},{"id":2492984,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-29T17:46:33.000Z","date":"2021-11-26","kind":"purchase","acquired":true,"shares":5000,"price":7.5543,"value":37771.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.07 to $7.70, inclusive."}],"balance_after":88775,"source":{"system":"sec-edgar","filing":"0001493152-21-029973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221029973/ownership.xml","form_type":"4"}},{"id":2492983,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-29T17:46:33.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":3266,"price":7.0937,"value":23168.0242,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.17, inclusive."}],"balance_after":83775,"source":{"system":"sec-edgar","filing":"0001493152-21-029973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221029973/ownership.xml","form_type":"4"}},{"id":2492982,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-29T17:46:33.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":6734,"price":6.2991,"value":42418.1394,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.97 to $6.96, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4."}],"balance_after":80509,"source":{"system":"sec-edgar","filing":"0001493152-21-029973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221029973/ownership.xml","form_type":"4"}},{"id":2541438,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:20:33.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":600000,"derivative":{"underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-21-025602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025602/ownership.xml","form_type":"4"}},{"id":2633018,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-07-15T22:04:39.000Z","date":"2021-07-13","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 90,000 restricted stock units granted on July 13, 2021 (the \"Grant Date\") under the Issuer's 2020 Equity Incentive Plan which will vest 50% on the six month anniversary of the Grant Date and the remaining 50% on the one year anniversary of the Grant Date."}],"balance_after":105000,"source":{"system":"sec-edgar","filing":"0001104659-21-092712","document":"tm2122331-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465921092712/tm2122331-1_4seq1.xml","form_type":"4"}},{"id":2665677,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-06-16T17:00:39.000Z","date":"2021-06-14","kind":"purchase","acquired":true,"shares":10000,"price":8.3,"value":83000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.75 to $8.49, inclusive. The reporting person undertakes to provide to Synaptogenix, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001104659-21-081897","document":"tm2119874d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524858/000110465921081897/tm2119874d1_4.xml","form_type":"4"}},{"id":2678094,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T20:00:47.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":39008,"price":5.1704,"value":201686.9632,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale of shares to satisfy tax withholding obligations upon the vesting of an award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.17 to $5.2183, inclusive. The reporting person undertakes to provide to AYRO, Inc., any security holder of AYRO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":135295,"source":{"system":"sec-edgar","filing":"0001493152-21-013812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315221013812/ownership.xml","form_type":"4"}},{"id":2743868,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-21T01:35:17.000Z","date":"2021-04-16","kind":"exercise","acquired":false,"shares":109500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":109500},"source":{"system":"sec-edgar","filing":"0001493152-21-009294","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009294/ownership.xml","form_type":"4"}},{"id":2743867,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T01:35:17.000Z","date":"2021-04-16","kind":"tax_withholding","acquired":false,"shares":38325,"price":4.94,"value":189325.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 38,325 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 109,500 shares of RSUs on April 16, 2021."}],"balance_after":71175,"source":{"system":"sec-edgar","filing":"0001493152-21-009294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009294/ownership.xml","form_type":"4"}},{"id":2743866,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T01:35:17.000Z","date":"2021-04-16","kind":"exercise","acquired":true,"shares":109500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."}],"balance_after":112101,"source":{"system":"sec-edgar","filing":"0001493152-21-009294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009294/ownership.xml","form_type":"4"}},{"id":2752193,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-09T20:15:24.000Z","date":"2021-04-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 25% on the date of grant, 25% shall vest upon the six-month anniversary of the date of grant and the remainder shall vest in equal installments over the following four fiscal quarters."}],"balance_after":50000,"derivative":{"exercise_price":3.18,"expiration_date":"2031-04-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-007861","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921007861/doc1.xml","form_type":"4"}},{"id":2830419,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-26T22:30:59.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted shares of common stock granted to the reporting person. 50% of such shares vest on June 30, 2021, and the remaining shares vest in two equal quarterly installments over the following six months."}],"balance_after":174303,"source":{"system":"sec-edgar","filing":"0001493152-21-004994","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315221004994/ownership.xml","form_type":"4"}},{"id":2931799,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T18:28:33.000Z","date":"2020-09-29","kind":"grant","acquired":true,"shares":122547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person's original Form 4 indicated that 5,668 shares of this grant vested in full on the date of grant, and the remaining 116,879 shares of this grant would vest in full on December 31, 2020. On December 24, 2020, the issuer and the reporting person mutually agreed to amend the vesting terms of the remaining 116,879 shares of this grant, with such shares now vesting in full on May 28, 2021, provided that the reporting person has remained employed by or is providing services to the issuer through the applicable vesting date."}],"balance_after":132303,"source":{"system":"sec-edgar","filing":"0001493152-20-024330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315220024330/ownership.xml","form_type":"4/A","original_submission_date":"2020-09-29"}},{"id":2957767,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:40:09.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":0.972,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-20-132149","document":"tm2037705d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132149/tm2037705d2_4.xml","form_type":"4"}},{"id":2957766,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:40:09.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":0.8203,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132149","document":"tm2037705d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132149/tm2037705d2_4.xml","form_type":"4"}},{"id":2957765,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:40:09.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":4.06,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132149","document":"tm2037705d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132149/tm2037705d2_4.xml","form_type":"4"}},{"id":2957764,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:40:09.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":3.93,"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-20-132149","document":"tm2037705d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132149/tm2037705d2_4.xml","form_type":"4"}},{"id":2957763,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:40:09.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":8.912,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132149","document":"tm2037705d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132149/tm2037705d2_4.xml","form_type":"4"}},{"id":2957762,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:40:09.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":167000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":19.62,"underlying":"Common Stock","underlying_shares":167000},"source":{"system":"sec-edgar","filing":"0001104659-20-132149","document":"tm2037705d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132149/tm2037705d2_4.xml","form_type":"4"}},{"id":2957761,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:40:09.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":19.1,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132149","document":"tm2037705d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132149/tm2037705d2_4.xml","form_type":"4"}},{"id":2957760,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:40:09.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":124275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":10.56,"underlying":"Common Stock","underlying_shares":124275},"source":{"system":"sec-edgar","filing":"0001104659-20-132149","document":"tm2037705d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132149/tm2037705d2_4.xml","form_type":"4"}},{"id":2957759,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:40:09.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":19.2,"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001104659-20-132149","document":"tm2037705d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132149/tm2037705d2_4.xml","form_type":"4"}},{"id":2957758,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-03T21:40:09.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the common stock was disposed of as follows: the reporting person received one (1) share of Petros Common Stock for every five (5) shares of Neurotrope common stock held."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-132149","document":"tm2037705d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132149/tm2037705d2_4.xml","form_type":"4"}},{"id":2961087,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Received in connection with the Transactions in exchange for a stock option to acquire 100,000 shares of Neurotrope common stock for $0.972 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"All shares subject to the option vested in connection with the Transactions."}],"balance_after":20000,"derivative":{"exercise_price":4.86,"expiration_date":"2030-11-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961086,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Received in connection with the Transactions in exchange for a stock option to acquire 10,000 shares of Neurotrope common stock for $0.82 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"All shares subject to the option shall vest on March 20, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":2000,"derivative":{"exercise_price":4.1,"expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961085,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Received in connection with the Transactions in exchange for a stock option to acquire 10,000 shares of Neurotrope common stock for $4.06 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"All shares subject to the option are vested as of the date hereof."}],"balance_after":2000,"derivative":{"exercise_price":20.3,"expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961084,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Received in connection with the Transactions in exchange for a stock option to acquire 150,000 shares of Neurotrope common stock for $3.93 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"28,125 shares subject to the option are vested as of the date hereof and the remaining shares subject to the option shall vest quarterly through January 22, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":30000,"derivative":{"exercise_price":19.65,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961083,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Received in connection with the Transactions in exchange for a stock option to acquire 10,000 shares of Neurotrope common stock for $8.912 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"All shares subject to the option are vested as of the date hereof."}],"balance_after":2000,"derivative":{"exercise_price":44.56,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961082,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":33400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Received in connection with the Transactions in exchange for a stock option to acquire 167,000 shares of Neurotrope common stock for $19.62 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"All shares subject to the option are vested as of the date hereof."}],"balance_after":33400,"derivative":{"exercise_price":98.1,"expiration_date":"2027-04-11","underlying":"Common Stock","underlying_shares":33400},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961081,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in connection with the Transactions in exchange for a stock option to acquire 10,000 shares of Neurotrope common stock for $19.10 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All shares subject to the option are vested as of the date hereof."}],"balance_after":2000,"derivative":{"exercise_price":95.5,"expiration_date":"2027-03-17","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961080,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":24855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in connection with the Transactions in exchange for a stock option to acquire 124,275 shares of Neurotrope common stock for $10.56 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares subject to the option are vested as of the date hereof."}],"balance_after":24855,"derivative":{"exercise_price":52.8,"expiration_date":"2026-11-22","underlying":"Common Stock","underlying_shares":24855},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961079,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":1875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in connection with the Transactions in exchange for a stock option to acquire 9,375 shares of Neurotrope common stock for $19.20 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1,623 shares subject to the option are vested as of the date hereof and the remaining shares subject to the option shall vest daily through August 4, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":1875,"derivative":{"exercise_price":96,"expiration_date":"2026-08-04","underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961078,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 100,000 shares of Neurotrope, Inc. (\"Neurotrope\") common stock in connection with the transactions (the \"Transactions\") contemplated by that certain Agreement and Plan of Merger, dated as of May 17, 2020 (the \"the Original Merger Agreement\"), as amended by the First Amendment to the Original Merger Agreement (the \"First Amendment\") , dated as of July 23, 2020 and the Second Amendment to the Original Merger Agreement, dated as of September 30, 2020 (the \"Second Amendment\" and, together with the Original Merger Agreement and the First Amendment, the \"Merger Agreement\") by and among Petros Pharmaceuticals, Inc. (the \"Company\"), Neurotrope, PM Merger Sub 1, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company (\"Merger Sub 1\"), PN Merger Sub 2, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (\"Merger Sub 2\"), and Metuchen Pharmaceuticals LLC, a Delaware limited liability company."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2965078,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-27T17:07:17.000Z","date":"2020-11-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will immediately vest and become exercisable subject to and upon consummation of (1) the merger of PM Merger Sub 1, LLC with and into Metuchen Pharmaceuticals, LLC (\"Metuchen\"), with Metuchen surviving as a wholly-owned subsidiary of Petros Pharmaceuticals, Inc. (\"Petros\") and (2) the merger of PN Merger Sub 2, Inc. with and into Neurotrope, Inc. (\"Neurotrope\"), with Neurotrope surviving as a wholly-owned subsidiary of Petros (together, the \"Mergers\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In the event the reporting person departs from the board of directors following the consummation of the Mergers, the options shall expire on the date that is one year from the date of the consummation of the Mergers."}],"balance_after":100000,"derivative":{"exercise_price":0.972,"expiration_date":"2030-11-24","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-20-130071","document":"tm2037145d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920130071/tm2037145d2_4.xml","form_type":"4"}},{"id":3002657,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T09:00:39.000Z","date":"2020-10-16","kind":"purchase","acquired":true,"shares":50000,"price":1.0889,"value":54445.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.10, inclusive. The reporting person undertakes to provide to Neurotrope, Inc., any security holder of Neurotrope, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001104659-20-116286","document":"tm2033760d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920116286/tm2033760d2_4.xml","form_type":"4"}},{"id":3003780,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-19T09:00:15.000Z","date":"2020-10-15","kind":"purchase","acquired":true,"shares":50000,"price":1.0663,"value":53315.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.04 to $1.09, inclusive. The reporting person undertakes to provide to Neurotrope, Inc., any security holder of Neurotrope, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001104659-20-115850","document":"tm2033760d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920115850/tm2033760d1_4.xml","form_type":"4"}},{"id":3018895,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T00:01:57.000Z","date":"2020-09-29","kind":"grant","acquired":true,"shares":122547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"5,668 shares of this grant vested in full on the date of grant, and the remaining 116,879 shares of this grant will vest in full on December 31, 2020, provided that the reporting person has continuously provided services to the issuer through that date."}],"balance_after":132303,"source":{"system":"sec-edgar","filing":"0001493152-20-018747","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315220018747/ownership.xml","form_type":"4"}},{"id":3033056,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-09-11T22:27:11.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":219000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\"). The Company may also elect to settle the vested RSUs for cash at its discretion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reporting Person was granted 219,000 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reporting Person was granted 219,000 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."}],"balance_after":219000,"derivative":{"underlying":"Common Stock","underlying_shares":219000},"source":{"system":"sec-edgar","filing":"0001493152-20-017672","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315220017672/ownership.xml","form_type":"4"}},{"id":3129540,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-02T00:26:21.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":9756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Such numbers have been revised to reflect a 1-for-10 reverse stock split of the Issuer's common stock effected on May 28, 2020 and a 1-for-1 stock dividend effected thereafter on May 28, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of restricted stock granted to the reporting person on May 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Such numbers have been revised to reflect a 1-for-10 reverse stock split of the Issuer's common stock effected on May 28, 2020 and a 1-for-1 stock dividend effected thereafter on May 28, 2020."}],"balance_after":9756,"source":{"system":"sec-edgar","filing":"0001493152-20-010333","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315220010333/ownership.xml","form_type":"4"}},{"id":3195889,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-24T18:02:18.000Z","date":"2020-03-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option award was made in connection with the Issuer's annual equity grants to non-employee directors pursuant to the terms of the Neurotrope, Inc. 2017 Equity Incentive Plan."}],"balance_after":10000,"derivative":{"exercise_price":0.8203,"exercise_date":"2021-03-20","expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-037867","document":"tm2013506d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920037867/tm2013506d5_4.xml","form_type":"4"}},{"id":3246917,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2020-02-27T01:26:00.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120000,"derivative":{"exercise_price":1.75,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-20-003039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220003039/ownership.xml","form_type":"4"}},{"id":3322055,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-01-04T00:07:56.000Z","date":"2020-01-01","kind":"exercise","acquired":true,"shares":5201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5201},"source":{"system":"sec-edgar","filing":"0001493152-20-000164","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315220000164/ownership.xml","form_type":"4"}},{"id":3322054,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-04T00:07:56.000Z","date":"2020-01-01","kind":"exercise","acquired":true,"shares":5201,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\")."}],"balance_after":5201,"source":{"system":"sec-edgar","filing":"0001493152-20-000164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315220000164/ownership.xml","form_type":"4"}}],"next_cursor":"2020-01-04T00:07:56.000000Z,3322054"}